-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Trainee Didactic Session: Show Me the Money - Funding Your Research

Symposia: Trainee Didactic Sessions Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Monday, December 11, 2023: 12:15 PM-1:15 PM
Room 31 (San Diego Convention Center)
Ifeyinwa Osunkwo, MD, MPH, Ify Osunkwo MD, MPH, formerly Director SCD Enterprise Atrium Health; Currently Chief Patient Officer / SVP Forma therapeutics
Osunkwo: Novo Nordisk: Consultancy, Current Employment, Current equity holder in publicly-traded company, Honoraria; Forma Therapeutics: Consultancy, Ended employment in the past 24 months, Honoraria; Global Blood Therapeutics: Consultancy, Speakers Bureau; Novartis: Consultancy, Honoraria; Takeda: Consultancy; Cheisi: Consultancy; Emmaus: Consultancy, Speakers Bureau; Agios: Consultancy; Acceleron: Consultancy.

Ifeyinwa Osunkwo, MD, MPH

Atrium Health, Charlotte, NC

Cassandra Dorothy Josephson, MD

Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, FL